CJC-1295 (no DAC) + Ipamorelin
Muscle/RecoveryPerformance / RecoveryExperimental
Synergistic GHRH/GHRP blend for pulsatile GH.
For research use only.
Key Facts
- CAS
- N/A (blend)
- Molecular Weight (MW)
- Varies
- Half-life
- CJC: ~30 min; Ipa: ~2 hours
- Unit
- mcg
- Administration Route
- Subcutaneous
- Frequency
- 1-2x daily
- Last updated
- 12/18/2025
- Targets
- Pituitary GH release
Overview
Synergistic GHRH/GHRP blend for pulsatile GH.
Protocol
- Dosage Range
- 100-200 mcg each
- Frequency
- 1-2x daily
- Cycle
- 8-12 weeks on, 4 weeks off
- Administration Route
- Subcutaneous
- Reconstitution Guide
- 3 mL BAC for 6mg/12mg blend
Science
Mechanism of Action
Synergistic GH stimulation.
Targets
Pituitary GH release
Studies
- — Journal/year not available
Benefits
GH optimizationRecoveryFat lossSleep quality
Potential Side Effects
- Flushing
- Headache
- Water retention